Advertisement

Topics

Altus Capital Partners, Inc. Company Profile

08:15 EDT 21st June 2018 | BioPortfolio

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing provides us with a unique understanding of the opportunities and challenges faced by companies in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. With offices in Wilton, CT and Lincolnshire, IL, Altus Capital Partners has completed 17 platform investments and numerous accretive add on acquisitions since 2003. For more information, please visit www.altuscapitalpartners.com/.


News Articles [1244 Associated News Articles listed on BioPortfolio]

Recipharm, Altus Enter Agreement

To further develop Altus’ patented INTELLITAB™ and FLEXITAB™ drug delivery technologies

Altus Formulation Inc.: Recipharm Signs Licensing Agreement with Altus Formulation

MONTREAL, QC / ACCESSWIRE / March 5, 2018 / Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug ...

Altus Capital Partners, Inc. Completes Tender Offer for MGC Diagnostics

Altus will support the company’s strategies for product innovation and growth Altus Capital Partners, Inc. (“Altus”), an investment firm focused on the Nor...

No chewing, grinding or snorting: Recipharm adds Altus anti-abuse tech

A license agreement will allow Recipharm to offer its customers Altus Formulationâs INTELLITAB and FLEXITAB anti-abuse drug delivery technologies.

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Centrexion raises $67mm in Series D round to fund Phase III trial for pain candidate CNTX4975

Pain-focused Centrexion Therapeutics Corp. raised $67mm in a Series D financing led by New Enterprise Associates. New and returning investors, including Quan Capital, ArrowMark Partners, investment fu...

CRMs for Highly Sensitive Instruments Need Ultrapure Water

ADEPT Pure Water, the specialists in water purification equipment, has supplied a centralised laboratory system to Certified Reference Materials (CRMs) provider Altus Science. Runcorn based Altus...

Honest Buildings Expands Series B Round to $21M with Additional Real Estate-Owner Investments

They join existing Series B industry investors Brookfield Property Partners, Rudin Ventures and C-III Capital Partners, in addition to leading venture capital funds Navitas Capital, Read more...

PubMed Articles [371 Associated PubMed Articles listed on BioPortfolio]

Health and social care coordination for severe and persistent mental illness in Australia: a mixed methods evaluation of experiences with the Partners in Recovery Program.

Care coordination has been identified as a person-centred response to the difficulty in meeting the needs of people with severe and persistent mental illness and complex needs. This study evaluated th...

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

Clinical Trials [330 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

Companies [1864 Associated Companies listed on BioPortfolio]

Altus Capital Partners, Inc.

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing prov...

Altus Pharmaceuticals Inc.

Altus® Pharmaceuticals is focused on developing and commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases. Altus' in-depth knowledge of protein ...

Altus Biologics

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value prot...

Altus Biologics Incorporated

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value prot...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

More Information about "Altus Capital Partners, Inc." on BioPortfolio

We have published hundreds of Altus Capital Partners, Inc. news stories on BioPortfolio along with dozens of Altus Capital Partners, Inc. Clinical Trials and PubMed Articles about Altus Capital Partners, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Altus Capital Partners, Inc. Companies in our database. You can also find out about relevant Altus Capital Partners, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...


Corporate Database Quicklinks



Searches Linking to this Company Record